Case No. | aDiscrepancies in secondary events | Secondary resumption –WBCT20 at Ha | Secondary resumption –WBCT30 at Ha | Recurrence of symptoms | Additional AA given | Final control WBCT20 at Ha | Final control WBCT30 at Ha | Resolution of symptoms |
---|---|---|---|---|---|---|---|---|
1 | Initial detection (Group 3a) | Remained normal | H6 | No, patient improving | No | H3, no resumption | H24 | H6 |
2 | No | H72 | H72 | Diffuse pain and headache | 2 vials at H72 | H120 | H120 | ≤ H96 |
a3 | Final resolution (Group 3b) | H72 | H72 | Edema and blistering | No, due to H0 anaphylaxis | H144 | H192 | H192 |
b10 | Initial detection (Group 3a) | H48 | H27 | Internal bleeding | 2 vials at H48 | H120 | H120 | ≤ H72 |
12 | Initial detection (Group 3a) | Remained normal | H24 | No, patient improving | No | H6, no resumption | H48 | H6 |
c19 | No | H24 | H24 | Gingival bleeding | 2 vials at H24 | H72 | H72 | H27 |
d22 | Transient resolution (Group 3b) | H96 and H168 | H96 | Internal bleeding | 2 vials at H120 2 vials at H168 | H240 | H240 | H192 |